Introduction to the eleventh conference on cancer therapy with antibodies and immunoconjugates

被引：1

作者：

Goldenberg, David M. ^{[1
]}

机构：

[1] Ctr Mol Med & Immunol, Garden State Canc Ctr, Belleville, NJ 07109 USA

来源：

CLINICAL CANCER RESEARCH | 2007年 / 13卷 / 18期

关键词：

D O I：

10.1158/1078-0432.CCR-07-1226

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：5499S / 5500S

页数：2

共 20 条

[1]

Boerman OC, 2003, J NUCL MED, V44, P400

[2]

Chang CH, 2002, MOL CANCER THER, V1, P553

[3] The dock and lock method: A novel platform technology for building multivalent, multifunctional structures of defined composition with retained bioactivity [J].

Chang, Chien-Hsing ;

Rossi, Edmund A. ;

Goldenberg, David M. .

CLINICAL CANCER RESEARCH, 2007, 13 (18) :5586S-5591S

[4] Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy:: A collaborative study with the French Endocrine Tumor Group [J].

Chatal, JF ;

Campion, L ;

Kraeber-Bodéré, F ;

Bardet, S ;

Vuillez, JP ;

Charbonnel, B ;

Rohmer, V ;

Chang, CH ;

Sharkey, RM ;

Goldenberg, DM ;

Barbet, J .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (11) :1705-1711

[5]

GOLDENBERG DM, 1990, CANCER RES, V50, pS778

[6] Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy [J].

Goldenberg, DM ;

Sharkey, RM ;

Paganelli, G ;

Barbet, J ;

Chatal, JF .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (05) :823-834

[7] Introduction to the tenth conference on cancer therapy with antibodies and immunoconjugates [J].

Goldenberg, DM .

CLINICAL CANCER RESEARCH, 2005, 11 (19) :7045S-7046S

[8]

Goldenberg DM, 1997, CANCER, V80, P2343, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2343::AID-CNCR1>3.0.CO

[9]

2-C

[10]

GOLDENBERG DM, 1991, ANTIBODY IMMUNOCONJ, V4, P387

← 1 2 →